AfterRaise/Companies/Celea Therapeutics

Celea Therapeutics

USABostonBiotech & PharmaUndisclosed

Overview

Where Celea Therapeutics is now

Celea Therapeutics announced a funding round of $180M on 2 July 2026, led by Sven Dethlefs.

Observed Described in the funding announcement as "clinical-stage biopharmaceutical company dedicated to advancing treatments for people with serious respiratory diseases". Source

Latest round
Undisclosed
Amount
$180M
Announced
2 July 2026
Headquarters
Boston, USA
Sector
Biotech & Pharma
Growth stage
Growth
Investors
Sven Dethlefs
Also participating
Not stated
Relevant leadership
Not stated

Current direction Inferred

What this company is working on

Research and development

Read from the company's own description of what the funding supports.

Momentum Inferred

AfterRaise Score

66
Building momentum
1 funding signal in the last 90 days
Funding recency
34/40
announced within the last 60 days
Round scale
22/25
round size relative to the market
Funding stage
10/20
Undisclosed
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Growth timeline

What has happened so far

  • 2 July 2026
    $180M raised
    Led by Sven Dethlefs.

Observed The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

Moves

Published by the company

Share a Move

No company-published Moves yet

AfterRaise has the funding facts for Celea Therapeutics from public sources. What it does not have is what the company is doing next, in the company's own words. That part only they can write.

Work here? Publish the first Move

Opportunities

Work this company has opened

No open Opportunities listed

Jobs, projects, partnerships and advisory needs appear here once the company has claimed its room and published them.

Work here? Open the first one

Open to

Who may approach Celea Therapeutics

Not yet specified

Celea Therapeutics has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Work here?

This room belongs to Celea Therapeutics.

Claim it to publish Moves in your own words, open Opportunities, choose who may approach you, and see the offers of help you have received. Everything you publish is reviewed before it appears.

Also moving

Other Biotech & Pharma companies

See the sector